Biomedical Diagnostics Overview

Principles

Definition

Biomedical diagnostics is an interdisciplinary field focused on the development and application of technologies and methodologies for the identification and characterization of physiological states, pathologies, and biomarkers within biological systems. This research area is crucial for enabling accurate clinical assessment, guiding therapeutic strategies, and advancing understanding of biological processes relevant to health and disease.

Ontological type

Core Technologies

Biomarker Types

Clinical Applications

Key developments

Key Figures

Label-Free Biosensing Foundations era

Isao Karube [1] was a leading figure in early label-free biosensing, with affiliations at The University of Osaka [3] and Lund University [4] in this era. His work, exemplified by Biosensors: fundamentals and applications [7], contributed key concepts for label-free transduction and real-time surface interrogation, laying the foundation for reproducible assay geometries central to this era. George S. Wilson [2] was a pivotal contributor with affiliations at University of Washington [5] and The University of Queensland [6] in this period. In Biosensors: fundamentals and applications [7], he helped articulate early signal processing and transduction strategies that underpinned non-invasive, real-time sensing and integrated device concepts characteristic of label-free biosensing foundations.

Multiplexed Miniaturized Diagnostics era

George M. Whitesides [1] was a central figure at Harvard University [2] and the Massachusetts Institute of Technology [3] during the Multiplexed Miniaturized Diagnostics era. His key contribution in this era was the patterned paper platform for inexpensive, low-volume, portable bioassays, demonstrated in Patterned Paper as a Platform for Inexpensive, Low-Volume, Portable Bioassays [4], which helped translate multiplexed readouts into disposable formats. This approach established scalable, low-cost substrates and simple fabrication workflows that propelled point-of-care diagnostics during this era, with Whitesides's work at Harvard University [2] and MIT [3] providing a blueprint. The 2007 paper Patterned Paper as a Platform for Inexpensive, Low-Volume, Portable Bioassays [4] exemplifies how distributed, low-cost diagnostics could achieve multiplexed measurements on durable substrates.

Programmable Point of Care era

Feng Zhang [1] is a pivotal figure associated with Harvard University [3] and the Institute of Cognitive and Brain Sciences [4] during the Programmable Point of Care era. In the 2018 Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6 [6], Zhang helped demonstrate a programmable, multiplexed nucleic acid detection platform that underpins rapid, field-deployable diagnostics, a keystone for programmable point-of-care systems. James J. Collins [2] is a renowned scientist at the Harvard–MIT Division of Health Sciences and Technology [5] and Harvard University [3] during this era. His collaboration on the same 2018 paper Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6 [6] helped advance portable, multiplexed CRISPR-based diagnostics, driving standardization and translation toward clinical adoption in programmable diagnostics.